Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma

Study investigated outcomes of patients with Hodgkin lymphoma treated with PD-1 inhibitors folllowing autologous stem cell transplant.